KEWAUNEE SCIENTIFIC CORP /DE/

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations $1.4m $19.1m $11.6m $10.5m
Net Income (Loss) Attributable to Parent $4.5m $5.2m $1.5m ($4.7m) ($3.7m) ($6.1m) $738k $18.8m $11.4m $9.6m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $4.6m $5.4m $1.7m ($4.6m) ($3.6m) ($6.0m) $1.4m $19.1m $11.6m
Net Income (Loss) Attributable to Noncontrolling Interest $105k $177k $159k $63k $65k $123k $621k $304k $178k
Depreciation, Depletion and Amortization $2.7m $2.8m $2.6m $2.7m $2.7m $2.8m $2.9m $3.1m $4.8m
Depreciation $2.7m $2.8m $2.6m $2.7m $2.7m $2.8m $2.9m $3.1m $4.0m
Depreciation Amortization Depletion $2.9m $3.1m $4.8m $6.3m
Deferred Income Tax Expense (Benefit) ($352k) $671k $27k $2.4m $242k $121k $515k ($11.0m) ($2.2m)
Deferred Income Tax $516k ($7.1m) ($2.2m) ($20k)
Deferred Tax $516k ($7.1m) ($2.2m) ($20k)
Share-based Payment Arrangement, Noncash Expense $355k $355k $197k $251k $634k $729k $886k $1.0m $1.4m
Share-based Payment Arrangement, Expense $199k
Goodwill and Intangible Asset Impairment $0 $0
Goodwill, Impairment Loss $0 $0
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $0 $0
Asset Impairment Charge $92k $120k
Income Tax Expense (Benefit) $2.1m $4.1m $446k $1.8m $990k $3.5m $3.1m ($5.9m) $3.2m
Interest Expense Nonoperating $3.2m $3.2m
Operating Lease, Expense $2.4m $2.4m $2.9m $3.1m $3.3m $3.5m $4.4m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $2.1m $3.1m $664k ($4.8m) $6.1m $8.5m $4.9m ($741k) $6.7m
Increase (Decrease) in Inventories ($691k) $2.7m ($456k) ($1.9m) $1.2m $7.3m ($1.9m) ($1.2m) ($3.4m)
Goodwill $12.5m $12.5m
Operating Expenses $20.1m $22.9m $23.2m $25.8m $25.3m $26.8m $30.2m $33.8m $51.1m
Payments of Financing Costs $1.5m $1.5m
Pension Cost (Reversal of Cost) $454k $454k $1.2m ($355k) $71k $4.2m $0
Beginning Cash Position $6.9m $13.8m $25.9m $17.2m
Cash Flow From Continuing Financing Activities $14.9m ($3.0m) $7.4m ($19.3m)
Cash Flow From Continuing Investing Activities ($4.1m) ($4.4m) ($30.9m) ($3.9m)
Change In Inventory $1.9m $1.2m $3.4m $2.3m
Change In Other Working Capital ($940k) $563k $785k ($666k)
Change In Payables And Accrued Expense ($5.6m) $691k $583k ($5.1m)
Change In Receivables ($4.9m) $741k ($6.7m) $3.3m
Change In Working Capital ($9.5m) $3.2m ($2.0m) ($194k)
Changes In Account Receivables ($8.5m) ($4.9m)
Changes In Cash $7.0m $12.2m ($8.7m) ($4.6m)
End Cash Position $13.8m $25.9m $17.2m $11.6m
Financing Cash Flow $14.9m ($3.0m) $7.4m ($19.3m)
Free Cash Flow ($7.9m) $15.2m $12.6m $14.7m
Investing Cash Flow ($4.1m) ($4.4m) ($30.9m) ($3.9m)
Net Business Purchase And Sale $0 ($28.7m) $0
Other Non Cash Items $1.2m ($368k)
Provisionand Write Offof Assets $120k $276k $68k $343k
Purchase Of Business $0 ($28.7m) $0
Repurchase Of Capital Stock $0 ($2.0m) ($1.6m) $0
Stock Based Compensation $886k $1.0m $1.4m $2.1m
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement ($4.0m) ($4.0m)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment ($1.3m) ($1.1m) ($884k) ($1.0m) ($1.7m) ($539k) ($628k)
Net Cash Provided by (Used in) Operating Activities $11.7m $3.2m $2.5m $4.2m $912k ($7.9m) ($3.8m) $19.6m $14.8m $18.6m
Cash flows from investing activities:
Capital Expenditure ($4.1m) ($4.4m) ($2.2m) ($3.9m)
Capital Expenditure Reported $2.6m $3.4m $4.2m $2.5m $2.4m $1.9m ($4.1m) ($4.4m) ($2.2m) ($3.9m)
Payments to Acquire Businesses, Net of Cash Acquired $28.7m $28.7m
Net Cash Provided by (Used in) Investing Activities ($2.5m) ($3.2m) ($4.2m) ($2.5m) ($2.4m) ($1.9m) ($4.1m) ($4.4m) ($30.9m)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $377k $377k $0 $202k
Issuance Of Debt $74.2m $148.3m $88.5m $26.6m
Long Term Debt Issuance $13.6m $202k $15.0m $10.2m
Net Issuance Payments Of Debt $15.5m ($1.0m) $10.8m ($18.3m)
Net Long Term Debt Issuance $13.5m ($528k) $12.9m ($17.4m)
Net Short Term Debt Issuance $2.0m ($488k) ($2.1m) ($912k)
Short Term Debt Issuance $60.6m $148.1m $73.5m $16.4m
Repayments of Long-term Debt $421k $918k $1.2m $1.3m $19k $0 $121k $88k
Long Term Debt Payments ($121k) ($730k) ($2.1m) ($27.6m)
Repayment Of Debt ($58.7m) ($149.3m) ($77.7m) ($44.9m)
Short Term Debt Payments ($58.6m) ($148.5m) ($75.6m) ($17.3m)
Net Common Stock Issuance $0 ($2.0m) ($1.6m) $0
Payments for Repurchase of Common Stock $2.0m $2.0m $1.6m
Payments of Ordinary Dividends, Common Stock $1.6m $1.8m $2.0m $1.0m $0
Common Stock Payments $0 ($2.0m) ($1.6m) $0
Net Other Financing Charges ($575k) ($642k) ($1.8m) ($1.0m)
Net Cash Provided by (Used in) Financing Activities ($2.1m) ($2.5m) $2.3m ($7.5m) $2.0m $11.0m $14.9m ($3.0m) $7.4m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $185k ($287k) ($413k) ($179k) $19k ($75k) ($72k) ($54k) ($67k)
Effect Of Exchange Rate Changes ($72k) ($54k) ($67k) ($917k)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $185k ($287k) $198k ($5.9m) $516k $1.2m $6.9m $12.1m ($8.8m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($3.0m) $11.2m $5.2m $5.7m $6.9m $13.8m $25.9m $17.2m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported $6.9m $12.1m ($8.8m) ($5.5m)
Interest Paid, Excluding Capitalized Interest, Operating Activities $295k $295k $352k $513k $65k $480k $1.9m $1.8m $3.4m $3.3m
Income Taxes Paid, Net $2.6m $2.9m $2.5m $188k ($1.8m) $1.0m $3.2m $6.2m $4.0m $3.6m